CLSI-based transference of the CALIPER database of pediatric reference intervals from Abbott to Beckman, Ortho, Roche

Mathew P Estey1, Ashley H Cohen, David A Colantonio

  • 1CALIPER Program, Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Canada.

Clinical Biochemistry
|April 13, 2013
PubMed

Insights

The CALIPER program expanded pediatric reference intervals to five major clinical chemistry platforms. This increases the global applicability of these essential biochemical markers for children and adolescents.

Area of Science:

  • Clinical Chemistry
  • Pediatric Reference Intervals
  • Biochemical Markers

Background:

  • The CALIPER program previously established pediatric reference intervals for 40 biochemical markers.
  • The initial database was limited to Abbott ARCHITECT assays.

Purpose of the Study:

  • To expand the CALIPER pediatric reference interval database to include assays from other major manufacturers.
  • To enhance the widespread clinical application of CALIPER reference intervals.

Main Methods:

  • Reference intervals were statistically transferred to Beckman Coulter, Ortho Vitros, Roche Cobas, and Siemens Vista platforms.
  • Validation involved 100 reference specimens from healthy children and adolescents.
  • External quality assessment (EQA) was conducted for all participating testing centers.

Main Results:

  • Transferred pediatric reference intervals generally aligned with previous findings.
  • Significant assay-specific differences in reference limits were observed for numerous analytes.
  • EQA results reflected the similarities and differences in reference limits across manufacturers.

Conclusions:

  • The study successfully extended the CALIPER reference interval database to five major analytical platforms.
  • This expansion facilitates the global use of CALIPER pediatric reference intervals in clinical settings.
Abstract

Related Concept Videos